SG10201805706XA - Immunoglobulin-like molecules directed against fibronectin-eda - Google Patents
Immunoglobulin-like molecules directed against fibronectin-edaInfo
- Publication number
- SG10201805706XA SG10201805706XA SG10201805706XA SG10201805706XA SG10201805706XA SG 10201805706X A SG10201805706X A SG 10201805706XA SG 10201805706X A SG10201805706X A SG 10201805706XA SG 10201805706X A SG10201805706X A SG 10201805706XA SG 10201805706X A SG10201805706X A SG 10201805706XA
- Authority
- SG
- Singapore
- Prior art keywords
- immunoglobulin
- molecules
- eda
- directed against
- molecules directed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2011944 | 2013-12-12 | ||
| NL2011943 | 2013-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201805706XA true SG10201805706XA (en) | 2018-08-30 |
Family
ID=52392177
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201805706XA SG10201805706XA (en) | 2013-12-12 | 2014-12-12 | Immunoglobulin-like molecules directed against fibronectin-eda |
| SG11201604748YA SG11201604748YA (en) | 2013-12-12 | 2014-12-12 | Immunoglobulin-like molecules directed against fibronectin-eda |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201604748YA SG11201604748YA (en) | 2013-12-12 | 2014-12-12 | Immunoglobulin-like molecules directed against fibronectin-eda |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10011652B2 (ko) |
| EP (1) | EP3080163B1 (ko) |
| JP (1) | JP6698529B2 (ko) |
| KR (1) | KR20160108322A (ko) |
| CN (1) | CN106170496B (ko) |
| AU (1) | AU2014360946B2 (ko) |
| BR (1) | BR112016013641A2 (ko) |
| CA (1) | CA2933471A1 (ko) |
| IL (1) | IL246187A0 (ko) |
| MX (1) | MX2016007691A (ko) |
| NZ (1) | NZ721984A (ko) |
| SG (2) | SG10201805706XA (ko) |
| WO (1) | WO2015088348A1 (ko) |
| ZA (1) | ZA201604048B (ko) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201805706XA (en) | 2013-12-12 | 2018-08-30 | Umc Utrecht Holding Bv | Immunoglobulin-like molecules directed against fibronectin-eda |
| CA2970427A1 (en) * | 2014-12-12 | 2016-06-16 | Encare Biotech B.V. | Immunoglobulin-like molecules directed against fibronectin-eda |
| GB201507908D0 (en) | 2015-05-08 | 2015-06-24 | Philogen Spa | IL2 and TNF immunoconjugates |
| CN108276491B (zh) * | 2018-02-05 | 2021-01-12 | 南京薇熙生物医药科技有限公司 | 一种可特异性识别hpv18 l1蛋白的单克隆抗体及其应用 |
| WO2019212341A2 (en) | 2018-05-03 | 2019-11-07 | Encore Biotech B.V. | Improved anti-fibronectin eda antibodies |
| CN111704653B (zh) * | 2020-06-08 | 2023-10-03 | 深圳市图微安创科技开发有限公司 | 靶向于纤连蛋白衍生肽的抑制剂多肽化合物及其用途 |
| DE202022100356U1 (de) | 2022-01-22 | 2022-03-08 | Fahad Ahmed Al Abbasi | Ein System zur Analyse der Wirkung von Vitamin C bei stressinduzierten Herzfunktionsstörungen |
| WO2023170170A1 (en) | 2022-03-08 | 2023-09-14 | Fundación Para La Investigación Médica Aplicada | New chimeric antigen receptor (car) cells and medical uses thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4980279A (en) | 1986-04-15 | 1990-12-25 | Scripps Clinic And Research Foundation | Cellular fibronectin: polypeptides, anti-polypeptide antibodies and assay methods |
| US5843708A (en) | 1988-01-05 | 1998-12-01 | Ciba-Geigy Corporation | Chimeric antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5108898A (en) * | 1989-01-18 | 1992-04-28 | Peters John H | Use of fibronectin having a variable included type III repeat sequence as a marker for toxemia in pregnancy |
| US5420012A (en) | 1989-05-08 | 1995-05-30 | Locus Genex Oy | Method for the detection of reactive conditions |
| WO1992017604A1 (en) | 1991-03-26 | 1992-10-15 | Otsuka Pharmaceutical Factory, Inc. | Anti-eda monoclonal antibody |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| US5644033A (en) | 1992-12-22 | 1997-07-01 | Health Research, Inc. | Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment |
| EP2299275B1 (en) * | 2004-07-30 | 2018-03-07 | Adeza Biomedical Corporation | Classification of the oncofetal fibronection level for pregnancy-related indications |
| ATE497508T1 (de) * | 2004-10-01 | 2011-02-15 | Max Planck Gesellschaft | Gegen das säugetier-eag1-ionenkanalprotein gerichtete antikörper |
| CA2609234C (en) * | 2005-06-01 | 2014-04-22 | Micromet Ag | Anti-il2 antibodies |
| CA2682851C (en) * | 2007-04-02 | 2017-01-17 | Philogen S.P.A. | A novel antigen associated with the neovasculature of tumour metastases |
| WO2008130635A2 (en) * | 2007-04-19 | 2008-10-30 | The Texas A&M University System | Formation of superfibronectin by bbk32 and uses therefor |
| ES2398536T3 (es) * | 2007-07-25 | 2013-03-20 | Philogen S.P.A. | El antígeno ED-A de fibronectina está asociado con la neovasculatura de la metástasis tumoral |
| US20130274448A1 (en) | 2010-10-26 | 2013-10-17 | Umc Utrecht Holding B.V. | Method for preventing myocardial infarction-related complications |
| US20130224236A1 (en) * | 2010-11-03 | 2013-08-29 | University Of Washington | Hsv-1 epitopes and methods for using same |
| SG10201805706XA (en) | 2013-12-12 | 2018-08-30 | Umc Utrecht Holding Bv | Immunoglobulin-like molecules directed against fibronectin-eda |
| CA2970427A1 (en) | 2014-12-12 | 2016-06-16 | Encare Biotech B.V. | Immunoglobulin-like molecules directed against fibronectin-eda |
-
2014
- 2014-12-12 SG SG10201805706XA patent/SG10201805706XA/en unknown
- 2014-12-12 BR BR112016013641A patent/BR112016013641A2/pt not_active Application Discontinuation
- 2014-12-12 MX MX2016007691A patent/MX2016007691A/es unknown
- 2014-12-12 NZ NZ721984A patent/NZ721984A/en not_active IP Right Cessation
- 2014-12-12 KR KR1020167017396A patent/KR20160108322A/ko not_active Application Discontinuation
- 2014-12-12 WO PCT/NL2014/050859 patent/WO2015088348A1/en active Application Filing
- 2014-12-12 CA CA2933471A patent/CA2933471A1/en not_active Abandoned
- 2014-12-12 US US15/103,677 patent/US10011652B2/en not_active Expired - Fee Related
- 2014-12-12 EP EP14828328.6A patent/EP3080163B1/en active Active
- 2014-12-12 AU AU2014360946A patent/AU2014360946B2/en not_active Ceased
- 2014-12-12 JP JP2016539063A patent/JP6698529B2/ja not_active Expired - Fee Related
- 2014-12-12 CN CN201480075378.6A patent/CN106170496B/zh not_active Expired - Fee Related
- 2014-12-12 SG SG11201604748YA patent/SG11201604748YA/en unknown
-
2016
- 2016-06-13 IL IL246187A patent/IL246187A0/en unknown
- 2016-06-14 ZA ZA2016/04048A patent/ZA201604048B/en unknown
-
2018
- 2018-06-08 US US16/003,160 patent/US10723789B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN106170496B (zh) | 2019-10-08 |
| JP6698529B2 (ja) | 2020-05-27 |
| KR20160108322A (ko) | 2016-09-19 |
| US20180346557A1 (en) | 2018-12-06 |
| WO2015088348A1 (en) | 2015-06-18 |
| NZ721984A (en) | 2020-01-31 |
| CN106170496A (zh) | 2016-11-30 |
| US20160368974A1 (en) | 2016-12-22 |
| SG11201604748YA (en) | 2016-07-28 |
| US10011652B2 (en) | 2018-07-03 |
| ZA201604048B (en) | 2018-05-30 |
| JP2017506061A (ja) | 2017-03-02 |
| EP3080163B1 (en) | 2020-02-12 |
| BR112016013641A2 (pt) | 2017-08-08 |
| EP3080163A1 (en) | 2016-10-19 |
| IL246187A0 (en) | 2016-07-31 |
| US10723789B2 (en) | 2020-07-28 |
| MX2016007691A (es) | 2017-05-01 |
| AU2014360946A1 (en) | 2016-07-14 |
| CA2933471A1 (en) | 2015-06-18 |
| AU2014360946B2 (en) | 2020-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201805706XA (en) | Immunoglobulin-like molecules directed against fibronectin-eda | |
| PH12019500694A1 (en) | Factor viii compositions and methods of making and using the same | |
| SG10201906859PA (en) | Novel proteins specific for angiogenesis | |
| MX2018009524A (es) | Composiciones del polipeptido de fusion tnfr: fc exentas de arginina y metodos de uso. | |
| IL294314A (en) | Proteins based on the scaffolding domain of fibronectin that bind to myostatin | |
| MX2017014125A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| WO2015028969A3 (en) | Transduction buffer | |
| EP4223772A3 (en) | Optimized factor viii gene | |
| TN2014000360A1 (en) | Cx3cr1-binding polypeptides | |
| MX2021008318A (es) | Nuevos polipeptidos de union especifica y usos de los mismos. | |
| MX2019001095A (es) | Proteinas de dominio de armazon basadas en fibronectina que se unen a la proteina convertasa subtilisina kexina tipo q (pcsk9). | |
| WO2014076321A8 (en) | Novel specific-binding polypeptides and uses thereof | |
| EP3321360A3 (en) | Alpha-amylase variants and polynucleotides encoding same | |
| IN2014DN06164A (ko) | ||
| WO2015110473A3 (en) | Pullulanase variants and polynucleotides encoding same | |
| MX2015000754A (es) | Proteinas de btnl3, acidos nucleicos, y anticuerpos y los usos de los mismos. | |
| WO2013163590A3 (en) | Gh61 polypeptide variants and polynucleotides encoding same | |
| WO2016044436A3 (en) | Anti-vasa antibodies, and methods of production and use thereof | |
| MX2017007663A (es) | Moleculas tipo inmunoglobulina dirigidas contra fibronectina eda. | |
| MX2016000774A (es) | Polipeptidos que tienen actividad alfa-xilosidasa y polinucleotidos que los codifican. | |
| BR112015019719A2 (pt) | Proteínas melhoradas de ligação ao tnf | |
| WO2016138167A3 (en) | Cellobiohydrolase variants and polynucleotides encoding same | |
| WO2015091959A3 (en) | Alpha-amylase variants and polynucleotides encoding same | |
| WO2015022077A8 (en) | Novel anti-fc-gamma receptor iib antibodies and uses thereof | |
| WO2015079064A3 (en) | Peroxygenase variants |